BIJON medica - Company finances
|
EUR
|
2020
From: 2020-02-20
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|
|
Financial data
|
||||||
| Sales revenue | 88,610 | 230,502 | 431,368 | 444,290 | 734,355 | 749,837 |
| Profit before tax | - | - | -43,515 | -22,253 | 33,223 | -55,681 |
| Net profit | -34,519 | -64,770 | -43,515 | -22,820 | 26,934 | -62,881 |
| Equity | -32,019 | -96,789 | -140,304 | -163,124 | -136,190 | -199,071 |
| Liabilities | 123,658 | 473,223 | 519,122 | 347,289 | 685,006 | 708,760 |
| Non-current assets | 20,870 | 42,357 | 42,922 | 55,410 | 40,986 | 51,195 |
| Current assets | 70,769 | 333,785 | 300,052 | 122,778 | 501,553 | 454,931 |
| Total assets | 91,639 | 376,142 | 342,974 | 178,188 | 542,539 | 506,126 |
|
Financial indicators
|
||||||
| Revenue change y/y | - | +160.1% | +87.1% | +3.0% | +65.3% | +2.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -37.7% | -17.2% | -12.7% | -12.8% | 5.0% | -12.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -39.0% | -28.1% | -10.1% | -5.1% | 3.7% | -8.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | -10.1% | -5.0% | 4.5% | -7.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 44,305 | 115,251 | 207,060 | 222,145 | 352,496 | 359,928 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
BIJON medica - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-04-24 | 2026-04-26 | 2.92 |
| 2026-03-29 | 2026-03-29 | 690.46 |
| 2026-03-17 | 2026-03-27 | 833.66 |
| 2022-08-23 | 2022-09-11 | 0.13 |
| 2022-07-25 | 2022-08-11 | 0.13 |
BIJON medica - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
BIJON medica, UAB (code 305474012) is a private limited liability company engaged in the wholesale of pharmaceutical and medical goods. In 2025, the company generated EUR 749.8K in revenue, up 2.1% year on year and 68.8% over two years. Profitability weakened materially: net profit fell to EUR -62.9K in 2025 from EUR 26.9K in 2024, after a loss of EUR -22.8K in 2023. The 2025 net profit margin was -8.4%, compared with 3.7% in 2024 and -5.1% in 2023, showing a volatile earnings profile despite rising sales. At year-end 2025, total assets stood at EUR 506.1K, including EUR 454.9K in short-term assets and EUR 51.2K in long-term assets. Equity remained negative at EUR -199.1K, while liabilities were EUR 708.8K. Asset turnover was 1.48x, indicating relatively efficient use of the asset base in revenue generation. Revenue per employee reached EUR 374.9K, while profit per employee was EUR -31.4K. The negative equity position also makes leverage and return-on-equity indicators difficult to interpret in a standard way.